Sorafenib Terminated Phase N/A Trials for Hepatocellular,Carcinoma / Liver Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02748304Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma
NCT01005875Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma